{
    "Project Title": "Longitudinal Quality of Life Study Among Participants with AIDS-Associated Kaposi Sarcoma at Bugando Medical Centre, in Mwanza, Tanzania",
    "Sponsor": "AIDS Malignancy Consortium",
    "Study Number": "AMC-S007",
    "Protocol Version and Date": "Version 2.0, Date 20MAR2018",
    "Study Title": "Longitudinal Quality of Life Study Among Participants with AIDS-Associated Kaposi Sarcoma at Bugando Medical Centre, in Mwanza, Tanzania",
    "Phase": "Pilot",
    "Therapeutic Area": "HIV-associated Kaposi Sarcoma",
    "Number of Patients": "20",
    "Number of Sites": "1",
    "Indication": "Kaposi Sarcoma",
    "Duration of Treatment": "6 cycles of chemotherapy every 21 days",
    "Schedule of Assessments": "Appendix I, Schedule of Evaluations",
    "questionnaires": [
        {
            "longName": "Functional Assessment of Cancer Therapy - General",
            "shortName": "FACT-G",
            "type": "PRO",
            "questionnaireSchedule": "Administered at baseline, after 3 cycles (cycle 4), at treatment discontinuation, and 3 months after treatment discontinuation.",
            "questionnaireTiming": [
                "Cycle 1",
                "Cycle 4",
                "Treatment Discontinuation",
                "Off Study"
            ]
        }
    ]
}